Interferon alfa-2A (IFN) and amantadine (A) or placebo (P) in IFN-naive patients with chronic hepatitis C (CHC): a doouble-blind, randomized, placebo-controlled trial (SASL 8): B Helbling, R Hermann, I Stamenic, University Hospital Zurich, Zurich Switzerland; F Viani, Jj Gonvers, University Hospital Lausanne, Lausanne Switzerland; Jf Dufour, J Reichen, University Hospital Bern, Bern Switzerland; G Cathomas, University Hospital Zurich, Zurich Switzerland; M Steuerwald, University Hospital Basel, Basel Switzerland; J Borovicka, Cantonal Hosp St Gallen, St Gallen Switzerland; El Renner, University Hospital Zurich, Zurich Switzerland; and the Investigators of the Swiss Assoc for the Study of the Liver (SASL), Switzerland

• Book ID: 118689015
• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 209 KB
• Volume: 34
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1053/s0270-9139(00)82766-4